Adverse drug reactions and off-label and unlicensed medicines in children: a prospective cohort study of unplanned admissions to a paediatric hospital.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  2014-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/bcp.12222PMID 23919928PMCID PMC4371534
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adverse Drug Reactions Causing Admission to a Paediatric Hospital

  2012cited by this paper
• Adverse drug reaction-related admissions in paediatrics, a prospective single-centre study

  2012cited by this paper
• Development and Inter-Rater Reliability of the Liverpool Adverse Drug Reaction Causality Assessment Tool

  2011cited by this paper
• Off-label and unlicensed medicine use and adverse drug reactions in children: a narrative review of the literature

  2011cited by this paper
• Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes

  2009cited by this paper
• Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil

  2008cited by this paper
• Adverse drug reactions: a cohort study in internal medicine units at a university hospital

  2006cited by this paper
• Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety

  2006cited by this paper
• The Impact of Unlicensed and Off-Label Drug Use on Adverse Drug Reactions in Paediatric Patients

  2004cited by this paper
• Risk factors for unlicensed and off-label drug use in children outside the hospital.

  2003cited by this paper
• Determinants for drug prescribing to children below the minimum licensed age

  2003cited by this paper
• Adverse Drug Reactions to Off-label Drugs on a Paediatric Ward: an Italian Prospective Pilot Study

  2002cited by this paper
• Adverse drug reactions and off-label drug use in paediatric outpatients.

  2002cited by this paper
• Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies.

  2001cited by this paper
• Risk factors for the development of adverse drug events in hospitalized patients

  2000cited by this paper
• Adverse drug reactions to unlicensed and off‐label drugs on paediatric wards: a prospective study

  1999cited by this paper
• Adverse drug reactions in general pediatric outpatients.

  1985cited by this paper

• PED-X-Bench: A Benchmark of Adult-to-Pediatric Extrapolation Decisions in FDA Drug Labels

  2025cites this paper
• Prescribing for children

  2025cites this paper
• Analysis of off-label drug use and its influencing factors in pediatric patients undergoing otolaryngology, head, and neck surgery

  2025cites this paper
• Decisional capacity to consent to treatment in children and adolescents: A systematic review.

  2024cites this paper
• The epidemiology of drug-related hospital admissions in paediatrics – a systematic review

  2024cites this paper
• Uso “off label” de inmunoglobulina g endovenosa en un hospital pediátrico de alta complejidad de Argentina Estudio observacional prospectivo

  2024cites this paper
• Understanding the informal aspects of medication processes to maintain patient safety in hospitals: a sociotechnical ethnographic study in paediatric units

  2024cites this paper
• Authorized or Off-Label Use? A Structured Analysis of Summaries of Product Characteristics with Regard to Authorization in Pediatrics

  2024cites this paper
• A narrative review on adverse drug reactions of COVID-19 treatments on the kidney

  2024cites this paper
• Paediatric Rheumatology Fails to Meet Current Benchmarks, a Call for Health Equity for Children Living with Juvenile Idiopathic Arthritis, Using Digital Health Technologies

  2024cites this paper
• Evaluation of healthcare professionals’ experiences of taking telephone calls from parents of children with congenital heart disease. A risky business

  2024cites this paper
• Guidance Documents for Off‐Label Drug Use Management for Chinese Health Care Institutions: A Scoping Review

  2024cites this paper
• Factors affecting the patient journey and patient care when receiving an unlicensed medicine: A systematic review.

  2023cites this paper
• Off‐label and unlicensed medicine prescribing in university hospital paediatric wards in Finland: A prospective study

  2023cites this paper
• Off-Label Prescribing in Pediatric Population—Literature Review for 2012–2022

  2023cites this paper
• Machine learning in medication prescription: A systematic review

  2023cites this paper
• Advances in pharmacokinetic-pharmacodynamic modelling for pediatric drug development: extrapolations and exposure-response analyses

  2023cites this paper
• What are the considerations when initiating treatment for epilepsy in children?

  2023cites this paper
• A Complex Intervention to Prevent Medication-Related Hospital Admissions-Results of the Stepped-Wedge Cluster Randomized Trial KiDSafe in Pediatrics.

  2023cites this paper
• Prescribed medicine use and extent of off‐label use according to age in a nationwide sample of Australian children

  2022cites this paper
• Paediatric drug development and evaluation: Existing challenges and recommendations.

  2022cites this paper
• Safety of Off-Label Pharmacological Treatment in Pediatric Neuropsychiatric Disorders: A Global Perspective From an Observational Study at an Italian Third Level Children’s Hospital

  2022cites this paper
• Unlicensed medicine prescribing in general practice

  2022cites this paper
• Downstream processing of amorphous solid dispersions into orodispersible tablets.

  2022cites this paper
• Medical treatment in infants and young children with epilepsy: Off‐label use of antiseizure medications. Survey Report of ILAE Task Force Medical Therapies in Children

  2022cites this paper
• Développement des médicaments en pédiatrie: défis existants et recommandations

  2022cites this paper
• Off‐Label, but on‐Evidence? A Review of the Level of Evidence for Pediatric Pharmacotherapy

  2022cites this paper
• Systematic Data Monitoring and Analysis of Cardiovascular Off-label Prescriptions in Pediatrics: Focus on Angiotensin-Converting Enzyme Inhibitors (ACE-I) and Beta Blockers

  2022cites this paper
• Development and Adjustment of an Algorithm for Identifying Drug-Related Hospital Admissions in Pediatrics

  2021cites this paper
• Benefit‐Risk Assessment of Off‐Label Drug Use in Children: The Bravo Framework

  2021cites this paper
• Anwendungspraktische Limitationen bei der Aufklärung im Rahmen von Arzneimitteltherapien

  2021cites this paper
• c4c: Paediatric pharmacovigilance: Methodological considerations in research and development of medicines for children – A c4c expert group white paper

  2021cites this paper
• Use in Children: The Bravo Framework

  2021cites this paper
• A brief analysis of parenteral medicines delivered in community pharmacies for off-label use in pediatric

  2021cites this paper
• Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough?

  2021cites this paper
• Off-Label Use of Cardiovascular Drugs in the Home Therapy of Children With Congenital or Acquired Heart Disease.

  2021cites this paper
• Orodispersible tablets for pediatric drug delivery: current challenges and recent advances

  2021cites this paper
• Evaluation of Adverse Drug Reactions in Paediatric Patients: A Retrospective Study in Turkish Hospital

  2021cites this paper
• Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database

  2021influential citation
• Incidence of Suspected Serious Adverse Drug Reactions in Corona Virus Disease-19 Patients Detected by a Pharmacovigilance Program by Laboratory Signals in a Tertiary Hospital in Spain: Cautionary Data

  2020cites this paper
• Analysis of adverse drug reactions reported in a tertiary care children hospital.

  2020cites this paper
• Suspected Serious Adverse Drug Reactions in Hospitalized COVID-19 Patients

  2020cites this paper
• A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies: a focus on context, prevalence, and quality

  2020cites this paper
• The Regulatory Challenges for Drug Repurposing During the Covid-19 Pandemic: The Italian Experience

  2020cites this paper
• Safety of Anticancer Agents Used in Children: A Focus on Their Off-Label Use Through Data From the Spontaneous Reporting System

  2020cites this paper
• Population pharmacokinetics of olanzapine in children

  2020cites this paper
• Serious Adverse Drug Reactions and Safety Signals in Children: A Nationwide Database Study

  2020influential citation
• Unlicensed and off‐label prescription of drugs to children in primary health care: A systematic review

  2020cites this paper
• Understanding Pediatric Drug Lag Time: Review of Selected Drug Package Inserts.

  2020cites this paper
• Off-label use of pentazocine and the associated adverse events among pediatric surgical patients in a tertiary hospital in Northern Nigeria: a retrospective chart review

  2019cites this paper
• ANALYSIS OF THE USE OF DRUG CATEGORY OFF LABEL IN HOSPITAL PATIENTS AT HOSPITAL

  2019cites this paper
• Pharmacoepidemiological research for the development and evaluation of drugs in pediatrics.

  2019cites this paper
• Wie häufig betreffen Gegenanzeigen und Warnhinweise in deutschen Fachinformationen pädiatrische Patienten

  2019cites this paper
• Susceptibility to adverse drug reactions.

  2019cites this paper
• Intravenous drug use in neonatal intensive care units

  2019cites this paper
• Pattern and extent of off-label and unlicensed drug use in neonatal intensive care units in Iran

  2019cites this paper
• Suspected adverse drug reactions reported for Brazilian children: cross-sectional study.

  2019cites this paper
• Antimicrobial Stewardship in Pediatrics. Training, Prescribing and Surveillance: An Initiative in Outpatient Children

  2018cites this paper
• Off-label use and manipulations of antiepileptic drugs in children: Analysis of the outpatient prescriptions in a tertiary center.

  2018cites this paper
• Comparison of Unlicensed and Off-Label Use of Antipsychotics Prescribed to Child and Adolescent Psychiatric Outpatients for Treatment of Mental and Behavioral Disorders with Different Guidelines: The China Food and Drug Administration Versus the FDA

  2018cites this paper
• Off-label and unlicensed drug use in children population.

  2018cites this paper
• Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance

  2018cites this paper
• Industry Perspective of Pediatric Drug Development in the United States: Involvement of the European Union Countries

  2018cites this paper
• Safety and Efficacy of Off-label and Unlicensed Medicines in Children

  2018cites this paper
• Two decades of off-label prescribing in children: a literature review

  2018cites this paper
• Serious Adverse Events Associated with Off-Label Use of Azithromycin or Fentanyl in Children in Intensive Care Units: A Retrospective Chart Review

  2018cites this paper
• Clinical analysis and study of 844 children with adverse drug reactions in China

  2018cites this paper
• Reações adversas a antibióticos em crianças hospitalizadas – uma revisão sistemática

  2018cites this paper
• Solving the problem of dose optimization of children’s medicines

  2018cites this paper
• Risk factors for adverse drug reactions in pediatric inpatients: a systematic review

  2017cites this paper
• ADRs and Children: Knowledge and Methodological Standard in PASS (Post Authorization Safety Studies)

  2017cites this paper
• Assessment of off-label prescribing: profile, evidence and evolution.

  2017cites this paper
• Clinical profiles of adverse drug reactions spontaneously reported at a single Korean hospital dedicated to children with complex chronic conditions

  2017cites this paper
• Supply of unlicensed medicines to children: semi-structured interviews with carers

  2017cites this paper
• Reported Adverse Drug Reactions in Infants: A Nationwide Analysis in Malaysia

  2017cites this paper
• Enjeux des formulations orales liquides pédiatriques et initiatives récentes : illustration par la réalisation d’une solution de chlorhydrate de clonidine

  2017cites this paper
• Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?

  2016cites this paper
• Medicamentos magistrais em recém-nascidos e crianças hospitalizados

  2016cites this paper
• Films orodispersibles de tétrabénazine pour l’administration pédiatrique

  2016cites this paper
• The Medicine Good Use and the Role of Pharmacists

  2016cites this paper
• FARMACOLOGÍA DEL PACIENTE PEDIÁTRICO

  2016influential citation
• Magistral drugs in hospitalized newborns and children

  2016cites this paper
• Precision Dosing in Children

  2016cites this paper
• Off‐label and unlicensed use of medicinal products in the neonatal setting in the Slovak Republic

  2016cites this paper
• Off‐label and unlicensed medicines to hospitalised children in Norway

  2016cites this paper
• Magistral drugs in hospitalized newborns and children.

  2016cites this paper
• Drug-Induced Renal Damage in Preterm Neonates: State of the Art and Methods for Early Detection

  2015cites this paper
• Clinical Pharmacology and the Individualized Approach to Treatment

  2015cites this paper
• It is time to review how unlicensed medicines are used

  2015cites this paper
• Off-label and unlicensed utilization of drugs in a Brazilian pediatric hospital.

  2015cites this paper
• In vitro analysis of overall particulate contamination exposure during multidrug IV therapy: Impact of infusion sets

  2015cites this paper
• Off-Label Prescribing in Pediatric Outpatients

  2015cites this paper
• Perioperative systemische Schmerztherapie bei Kindern Österreichische interdisziplinäre Handlungsempfehlungen zum perioperativen Schmerzmanagement bei Kindern

  2014cites this paper
• Drug Safety in Children: Focus on hepatic concerns

  2014cites this paper
• Perioperative systemische Schmerztherapie bei Kindern

  2014cites this paper
• Pharmacovigilance reports of drug-related harms in children should include details on age- and drug-specific factors

  2014cites this paper
• Pharmacovigilance reports of drug-related harms in children should include details on age- and drug-specific factors

  2014cites this paper
• Adverse drug reactions in neonates: could we be documenting more?

  2014cites this paper
• ADRIC: Adverse Drug Reactions In Children – a programme of research using mixed methods

  2014cites this paper
• Erratum zu: Perioperative systemische Schmerztherapie bei Kindern. Österreichische interdisziplinäre Handlungsempfehlungen zum perioperativen Schmerzmanagement bei Kindern

  2014cites this paper